Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 8,068 | 5,890 | 5,840 | 7,691 | 6,160 |
| Gross Profit | 8,068 | 5,890 | 5,840 | 7,691 | 6,160 |
| Operating Expenses | 46,678 | 40,104 | 34,170 | 29,064 | 23,043 |
| Operating Income | -38,610 | -34,214 | -28,330 | -21,373 | -16,883 |
| Interest Expense | 47 | 59 | 72 | 91 | 109 |
| Other Income | 954 | 861 | 425 | 201 | 158 |
| Pre-tax Income | -37,703 | -33,412 | -27,977 | -21,263 | -16,834 |
| Net Income Continuous | -37,703 | -33,412 | -27,977 | -21,263 | -16,834 |
| Net Income | $-37,703 | $-33,412 | $-27,977 | $-21,263 | $-16,834 |
| EPS Basic Total Ops | -0.96 | -0.86 | -0.84 | -0.75 | -0.62 |
| EPS Basic Continuous Ops | -0.96 | -0.86 | -0.84 | -0.75 | -0.62 |
| EPS Diluted Total Ops | -0.96 | -0.86 | -0.84 | -0.75 | -0.62 |
| EPS Diluted Continuous Ops | -0.96 | -0.86 | -0.84 | -0.75 | -0.62 |
| EBITDA(a) | $-38,324 | $-33,831 | $-27,846 | $-20,883 | $-16,382 |